Pediatric Constipation

294 flashcardspar un étudiant OutLearn
Réviser ces flashcardsGratuit · répétition espacée · iPhone, Android, Mac et web

Toutes les cartes

1
What is the most common cause of abdominal pain in children?
Constipation
2
How long must difficulty or delay in defecation persist to meet the lecture's definition of constipation?
At least 2 weeks with significant distress
3
What percentage of pediatric office visits are due to constipation?
3–5%
4
What is the incidence of constipation among children aged 6–12 years?
More than 30%
5
Which sex is more commonly affected by constipation?
Males
6
What are the three broad etiologic categories of constipation?
Anatomic, functional, and medical
7
What is the worldwide prevalence of functional constipation?
Approximately 9.5%
8
What percentage of constipation cases in children older than 1 year are functional?
More than 95%
9
What is the most common age-related pattern of bowel movements in infants?
More frequent than older children and adults
10
How often should an adequately toilet-trained child older than 3 years ideally defecate?
At least once daily
11
What interval between bowel movements may be abnormal in adults?
More than 3 days
12
What is the mean daily bowel movement frequency in breastfed infants aged 0–3 months?
2.9 times
13
What is the mean daily bowel movement frequency in formula-fed infants aged 0–3 months?
2.0 times
14
What is the mean daily bowel movement frequency in infants aged 6–12 months?
1.8 times
15
What is the mean daily bowel movement frequency in children aged 1–3 years?
1.4 times
16
What is the mean daily bowel movement frequency in children older than 3 years?
1.0 time
17
What stool consistency scale is used to assess constipation?
Bristol Stool Form Scale
18
What stool appearance is commonly associated with functional constipation?
Large-diameter stools
19
What type of stool may suggest anatomic obstruction?
Ribbon-like stools
20
What is stool withholding?
Voluntary retention of stool to avoid painful defecation
21
What are common associated symptoms of constipation?
Pain, straining, hard stools, blood, withholding, soiling, and incomplete evacuation
22
What is the typical presentation of functional constipation?
Infrequent, hard, or painful stools with withholding or fecal incontinence
23
What is functional constipation considered diagnostically?
Diagnosis of exclusion
24
What underlying causes are absent in functional constipation?
Structural, neurologic, or systemic causes
25
What is the primary mechanism of functional constipation?
Painful defecation leading to voluntary stool withholding
26
What initiates the withholding-pain cycle?
Painful or frightening passage of a large, hard stool
27
What happens when a child voluntarily withholds stool?
Stool remains longer in the colon
28
What happens to stool during prolonged retention?
More water is absorbed, making stool harder and larger
29
What happens to the rectum during chronic stool retention?
Rectal distension and reduced sensation
30
What causes overflow fecal incontinence?
Retained stool with leakage around impacted feces
31
What reinforces the withholding-pain cycle?
Pain, fear, and avoidance
32
What social consequence can overflow soiling cause?
Foul odor and peer rejection
33
What is the typical withholding posture shown in the lecture?
Leg crossing or squatting
34
What is retentive posturing?
Posture adopted to avoid defecation
35
What is the Rome IV criterion for functional constipation in infants and children up to 4 years?
At least 2 criteria for at least 1 month
36
What is the Rome IV defecation-frequency criterion in children up to 4 years?
Two or fewer defecations per week
37
What is another Rome IV criterion in children up to 4 years?
History of excessive stool retention
38
What stool characteristic is included in Rome IV criteria for children up to 4 years?
Painful or hard bowel movements
39
What stool size is included in Rome IV criteria for children up to 4 years?
Large-diameter stools
40
What rectal finding is included in Rome IV criteria for children up to 4 years?
Large fecal mass in the rectum
41
What is the Rome IV criterion duration for children with developmental age of at least 4 years?
At least 1 month
42
How many criteria are required for Rome IV diagnosis in children aged at least 4 years?
At least 2 criteria
43
What is the frequency criterion for children aged at least 4 years?
Two or fewer toilet defecations per week
44
How frequent must fecal incontinence occur to meet a Rome IV criterion in children aged at least 4 years?
At least 1 episode per week
45
What behavioral finding qualifies as a Rome IV criterion in older children?
Retentive posturing or excessive stool retention
46
What abdominal finding qualifies as a Rome IV criterion in older children?
Large fecal mass in the rectum
47
What type of stools may obstruct the toilet in older children with constipation?
Large-diameter stools
48
What is an important neonatal history question when evaluating constipation?
When meconium was first passed
49
When should meconium normally be passed according to the lecture?
Within 24–48 hours after birth
50
What delayed meconium passage suggests an organic cause?
After 48 hours
51
What age of onset is an alarm feature for constipation?
During the first month of life
52
What stool shape is an alarm feature for constipation?
Ribbon-like or narrow stools
53
What type of rectal bleeding is an alarm feature?
Persistent blood in stools without an anal fissure
54
What type of vomiting is an alarm feature for constipation?
Bilious vomiting
55
What abdominal finding is an alarm feature?
Severe abdominal distension
56
What systemic symptoms are alarm features?
Fever or unexplained diarrhea
57
What growth finding suggests an organic cause of constipation?
Poor weight gain or failure to thrive
58
What family history is an alarm feature?
Hirschsprung disease or relevant genetic disorders
59
What does an abnormal anal position suggest?
Anorectal malformation
60
What neurologic findings are examination red flags?
Abnormal lower-limb tone or reflexes and absent anal wink
61
What sacral findings suggest spinal dysraphism?
Tuft of hair, deep sacral dimple, or gluteal cleft deviation
62
What growth findings are examination red flags?
Abnormal growth parameters
63
What are common infant causes of constipation?
Hirschsprung disease, anorectal malformations, neurologic disorders, and metabolic causes
64
What congenital neurologic conditions can cause constipation?
Myelomeningocele, spina bifida, and tethered cord
65
What metabolic conditions can cause constipation?
Hypothyroidism, hypercalcemia, hypokalemia, and diabetes insipidus
66
What genetic disease may cause constipation in children?
Cystic fibrosis
67
What gastrointestinal disease may cause constipation in older children?
Celiac disease
68
What medications may cause constipation?
Opioids, anticholinergics, iron, and some anticonvulsants
69
What is the primary pathologic abnormality in Hirschsprung disease?
Absence of ganglion cells in the myenteric plexus
70
What happens to the affected intestinal segment in Hirschsprung disease?
Persistent contraction
71
What happens to the normal proximal segment in Hirschsprung disease?
Dilatation due to stool accumulation
72
What condition results from proximal intestinal dilatation in Hirschsprung disease?
Megacolon
73
What is the characteristic onset of Hirschsprung disease?
Since birth or within 1–2 months of age
74
When does functional constipation commonly begin?
After 1 year of age
75
Is fecal soiling common in Hirschsprung disease?
No; feces do not pass normally
76
Is fecal soiling common in functional constipation?
Yes
77
Is straining during defecation typical of Hirschsprung disease?
No
78
Is straining during defecation typical of functional constipation?
Yes
79
Can patients with Hirschsprung disease commonly pass large, bulky stools?
No; ribbon-like stools may occur
80
Can patients with functional constipation pass large, bulky stools?
Yes
81
Are pain and bleeding during defecation typical of Hirschsprung disease?
Unusual
82
Why can pain and bleeding occur in functional constipation?
Mucosal tears
83
Are anal fissures usually present in Hirschsprung disease?
No
84
Are anal fissures common in functional constipation?
Yes
85
What is the typical rectal examination finding in Hirschsprung disease?
Empty rectum with explosive stool release after finger withdrawal
86
What is the typical rectal examination finding in functional constipation?
Rectum full of hard stool
87
What does a barium enema show in Hirschsprung disease?
Transition zone between narrowed distal and dilated proximal bowel
88
What is the beaking sign?
Characteristic beak-like appearance on barium enema
89
What is the diagnostic finding on rectal biopsy in Hirschsprung disease?
Absent ganglion cells
90
What is the rectal biopsy finding in functional constipation?
Ganglion cells are present
91
Which investigation definitively confirms Hirschsprung disease?
Rectal biopsy
92
What is the 2026 joint ESPGHAN/NASPGHAN treatment guideline's significance?
First updated treatment guideline since 2014
93
How many randomized trials were reviewed in the 2026 joint guideline?
102
94
How many recommendations were included in the 2026 guideline?
11 recommendations and 19 good-practice statements
95
Which constipation intervention received the only strong recommendation in the 2026 guideline?
Polyethylene glycol (PEG)
96
What is the 2025 NASPGHAN position paper about?
Pediatric refractory constipation
97
What does the 2026 NASPGHAN–AGA clinical care pathway emphasize?
Early recognition, stepwise care, and continuity
98
What are the main components of constipation diagnosis?
Rome IV criteria, focused history, and physical examination
99
What should be assessed during physical examination of a constipated child?
Growth, abdominal findings, perianal anatomy, sacral region, and neurologic status
100
What is assessed during abdominal palpation?
Fecal mass or abdominal distension
101
What is important when inspecting the perianal region?
Anal position and sacral anatomy
102
When should digital rectal examination be performed?
Only when indicated and appropriate
103
Is routine laboratory testing indicated in typical functional constipation?
No
104
Is routine abdominal radiography indicated for diagnosing constipation?
No
105
When should laboratory investigations be considered?
When red flags, atypical presentation, or refractory disease are present
106
Which laboratory tests may be considered for suspected organic constipation?
Celiac serology, TSH, and calcium
107
What are the three mainstays of initial functional constipation management?
Increase fluid and fiber intake and establish a regular bowel routine
108
What percentage of functional constipation cases improve with appropriate management?
90–95%
109
When is abdominal radiography appropriate in constipation?
When history or examination is unreliable or obstruction/distension is suspected
110
What test is used to evaluate RAIR and anorectal function?
Anorectal manometry
111
When is contrast enema indicated?
When Hirschsprung disease or an anatomic abnormality is suspected
112
What is the role of rectal biopsy in constipation evaluation?
Confirmation of Hirschsprung disease
113
What are the goals of constipation treatment?
Soft painless stools, clearing fecal loading, preventing recurrence, and restoring confidence
114
What should clinicians avoid when counseling families about constipation?
Blame, punishment, and shame
115
What is the first step before maintenance therapy?
Assess and treat fecal impaction
116
What clinical findings suggest fecal impaction?
Prolonged absence of voluntary stool passage and hard, difficult stools
117
Which Bristol Stool Form Scale types suggest hard stools and possible impaction?
Types 1–2
118
What examination finding suggests fecal impaction?
Palpable hard fecal mass
119
Can overflow fecal incontinence coexist with fecal impaction?
Yes
120
What are the treatment options for fecal disimpaction?
High-dose oral PEG or rectal enema
121
What is the common PEG disimpaction dose?
$1–1.5$ g/kg/day
122
How long is the common PEG disimpaction regimen?
3–6 days
123
What factors should guide enema selection?
Age, treatment burden, contraindications, and local protocol
124
Why should acceptability of rectal therapies be discussed?
They can be distressing to children
125
What is the first-line maintenance medication for pediatric functional constipation?
Polyethylene glycol (PEG 3350/4000)
126
What is the typical PEG maintenance dose?
$0.4–0.8$ g/kg/day
127
Can PEG be administered with or without electrolytes?
Yes
128
How should PEG maintenance dosing be adjusted?
According to response and tolerance
129
What stool characteristics are targeted during PEG maintenance therapy?
Soft, painless stools
130
What behavioral outcomes are targeted during PEG maintenance therapy?
Minimal withholding and minimal soiling
131
Why should PEG continue after disimpaction?
To prevent fecal re-accumulation
132
What are common adverse effects of PEG?
Bloating, abdominal discomfort, and loose stools
133
What should be explained when starting PEG?
Expected onset, mixing instructions, and adherence
134
Should PEG be stopped as soon as stool frequency improves?
No; review overall treatment response
135
When is lactulose useful in pediatric constipation?
When PEG is unavailable or not tolerated
136
What is the evidence recommendation for magnesium hydroxide?
Conditional recommendation with low-certainty evidence
137
What is the therapeutic role of senna, bisacodyl, and sodium picosulfate?
Adjunct, rescue, or selected maintenance therapy
138
What is linaclotide used for in selected pediatric constipation cases?
A suggested option with conditional recommendation
139
What is the evidence certainty for linaclotide?
Moderate-certainty evidence
140
What should be considered before prescribing linaclotide?
Specialist guidance and local approval
141
Is prucalopride suggested for pediatric functional constipation?
No; evidence shows no benefit
142
Are lubiprostone and domperidone suggested for pediatric functional constipation?
No
143
What is the role of toilet sitting in constipation management?
Relaxed, developmentally appropriate sitting after meals
144
What is the recommended foot position during toilet sitting?
Feet supported on a stool
145
How should the knees be positioned during toilet sitting?
Above the hips
146
What is the recommended trunk position during toilet sitting?
Lean forward
147
What behavioral approach should be used during toilet training?
Positive reinforcement
148
What should be avoided during toilet training?
Punishment
149
What tool helps monitor bowel habits during treatment?
Stool diary
150
What dietary intake should children with constipation maintain?
Normal age-appropriate fiber and fluid intake
151
Should excessive fluid or fiber intake be prescribed?
No
152
What physical activity is recommended for children with constipation?
Regular physical activity
153
Should behavioral therapy be used alone for constipation?
No; use it as an adjunct when indicated
154
What is the evidence certainty for pelvic floor physiotherapy in selected children?
Low-certainty evidence
155
What is the evidence for probiotics in pediatric constipation?
Low-certainty and strain-specific
156
When may a cow's milk-free trial be considered?
When conventional therapy fails and cow's milk allergy is suspected
157
How long should a cow's milk-free trial last?
2–4 weeks
158
Why should restrictive diets involve a dietitian?
To ensure nutritional adequacy
159
Is biofeedback alone recommended for pediatric constipation?
No
160
Can biofeedback be included in broader pelvic floor physiotherapy?
Yes
161
Are enemas and suppositories routine maintenance treatments?
No; they may be used in selected children
162
What is the minimum recommended duration of maintenance therapy?
At least 2 months
163
How long should symptoms be resolved before tapering treatment?
At least 1 month
164
Should maintenance therapy be stopped abruptly when improvement begins?
No; taper gradually
165
What stool parameters should be monitored during follow-up?
Frequency and consistency
166
What behavioral symptoms should be monitored during follow-up?
Pain, withholding, and fecal soiling
167
What treatment-related factors should be assessed during follow-up?
Adherence, dose adequacy, adverse effects, and family burden
168
How long may many children require constipation treatment?
Several months
169
What is the first requirement for diagnosing refractory constipation?
Meeting Rome IV criteria for functional constipation
170
How long must age-appropriate therapy fail before refractory constipation is considered?
At least 3 months
171
What medication is required in optimized therapy for refractory constipation?
Daily stimulant laxative
172
What interventions should accompany stimulant laxatives in refractory constipation?
Behavioral and biomechanical interventions
173
What persistent stool frequency supports refractory constipation?
Two or fewer voluntary defecations per week
174
What persistent fecal incontinence frequency supports refractory constipation?
At least 1 episode per week
175
What quality-of-life feature is required for refractory constipation?
Impaired quality of life of the child or family
176
What should be excluded before diagnosing refractory constipation?
Alarm features and organic disease
177
What treatment factors should be verified before labeling constipation refractory?
Adherence, dosage, duration, and medication access
178
What must be addressed before optimizing maintenance treatment?
Fecal impaction
179
Is failure of PEG alone sufficient to diagnose refractory constipation?
No; an adequate stimulant trial is needed
180
Which specialist team may manage refractory constipation?
Pediatric GI or motility team
181
Which serologic test should be obtained before invasive testing or surgery?
Celiac serology
182
When should thyroid testing be considered?
When suggestive alarm features are present
183
When is anorectal manometry considered?
To assess RAIR and anorectal function
184
When is spinal MRI considered?
For specialist-directed investigation of suspected spinal pathology
185
What is the role of multidisciplinary care in refractory constipation?
Optimize conventional treatment and coordinate specialist interventions
186
What specialist interventions may be considered in refractory constipation?
Linaclotide, pelvic floor physiotherapy, and transanal irrigation
187
When may botulinum toxin or surgery be considered?
Carefully selected refractory cases
188
Which professionals may participate in multidisciplinary constipation care?
Pediatrics, surgery, psychology, and dietetics
189
What are common constipation management pitfalls?
Under-treatment, premature discontinuation, and failure to disimpact
190
Why is relying only on dietary changes often inadequate?
It may fail to treat fecal impaction and chronic retention
191
Does daily stool passage exclude constipation?
No; retention and soiling may persist
192
Should fecal soiling be considered intentional misbehavior?
No
193
What is the likely diagnosis in a 5-year-old with painful large stools twice weekly, withholding, and weekly soiling?
Functional constipation by Rome IV
194
What should be addressed first in a child with functional constipation and palpable fecal mass?
Fecal disimpaction
195
What is the recommended initial management of functional constipation with impaction?
Disimpaction with oral PEG or an appropriate rectal option
196
What maintenance medication follows disimpaction?
PEG
197
What additional measures should accompany maintenance treatment?
Toilet routine, education, and follow-up
198
What are the key take-home principles for pediatric constipation?
Diagnose clinically, identify red flags, disimpact first, and use PEG first-line
199
What is the recommended duration of optimized treatment before diagnosing refractory constipation?
At least 3 months
200
What is the first step in bilirubin metabolism?
Breakdown of old red blood cells
201
What are the two components produced by red blood cell breakdown?
Heme and globin
202
What is heme converted into first?
Biliverdin
203
What is the next product after biliverdin?
Unconjugated bilirubin
204
What color is biliverdin?
Greenish
205
What type of bilirubin is unconjugated bilirubin?
Indirect bilirubin
206
Is unconjugated bilirubin fat-soluble or water-soluble?
Fat-soluble
207
Can unconjugated bilirubin be directly excreted in urine or bile?
No
208
What protein transports unconjugated bilirubin in the bloodstream?
Albumin
209
Which organ conjugates bilirubin?
Liver
210
Which liver cells perform bilirubin conjugation?
Hepatocytes
211
Which enzyme conjugates unconjugated bilirubin?
UDP-glucuronosyltransferase
212
What substance is attached to unconjugated bilirubin during conjugation?
Glucuronic acid
213
What type of bilirubin is produced after conjugation?
Conjugated or direct bilirubin
214
Is conjugated bilirubin fat-soluble or water-soluble?
Water-soluble
215
Where is conjugated bilirubin secreted?
Bile
216
Where does conjugated bilirubin enter after bile secretion?
Small intestine
217
What do gut bacteria convert conjugated bilirubin into?
Urobilinogen
218
What substance gives stool its brown color?
Stercobilin
219
What is most urobilinogen converted into?
Stercobilin
220
What happens to a small portion of urobilinogen?
Reabsorbed into blood and filtered by kidneys
221
What substance gives urine its yellow color?
Urobilin
222
What causes unconjugated hyperbilirubinemia?
Increased bilirubin production, impaired uptake, or defective conjugation
223
What enzyme defect can cause unconjugated hyperbilirubinemia?
UGT1A1 dysfunction
224
What is the major mechanism of unconjugated hyperbilirubinemia?
Hemolysis, impaired hepatic uptake, or defective conjugation
225
What are causes of unconjugated hyperbilirubinemia?
Physiological jaundice, breast milk jaundice, ABO/Rh isoimmunization, G6PD deficiency, and inherited syndromes
226
Which inherited syndromes cause unconjugated hyperbilirubinemia?
Crigler–Najjar and Gilbert syndromes
227
What causes conjugated hyperbilirubinemia?
Defective bile formation, excretion, or extrahepatic biliary obstruction
228
What is another name for conjugated hyperbilirubinemia?
Cholestasis
229
What are causes of conjugated hyperbilirubinemia?
Biliary atresia, Alagille syndrome, PFIC, alpha-1 antitrypsin deficiency, TORCH infections, and metabolic disorders
230
What does PFIC stand for?
Progressive familial intrahepatic cholestasis
231
What is the ESPGHAN/NASPGHAN two-week rule?
Evaluate infants with persistent jaundice for cholestasis
232
At what age must a jaundiced infant be evaluated for cholestasis?
At least 14 days
233
At what age may evaluation be extended for exclusively breastfed infants with reassuring findings?
At least 21 days
234
What direct bilirubin level is considered abnormal in the lecture?
Greater than 1.0 mg/dL
235
What is the equivalent abnormal direct bilirubin level in the lecture?
17 mmol/L
236
Does an abnormal direct bilirubin require investigation regardless of total serum bilirubin?
Yes
237
What screening tool can identify acholic stools early?
Stool color cards
238
What stool color suggests cholestasis?
Acholic or pale stools
239
What initial laboratory tests are included in the neonatal cholestasis workup?
Total and fractionated bilirubin, ALT, AST, GGT, alkaline phosphatase, albumin, and PT/INR
240
Which infectious investigations are included in the neonatal cholestasis workup?
TORCH panel, blood and urine cultures, CMV PCR, HSV, and enteroviruses
241
Which metabolic and genetic investigations are included in the neonatal cholestasis workup?
Newborn screen review, galactosemia testing, A1AT level/phenotype, and NGS panels
242
What imaging is used in neonatal cholestasis evaluation?
Fasted abdominal ultrasound
243
What ultrasound findings are assessed for suspected biliary atresia?
Gallbladder size, triangular cord sign, and extrahepatic bile duct anatomy
244
What invasive investigations may be used for neonatal cholestasis?
Percutaneous liver biopsy or intraoperative cholangiogram
245
Why is early identification of direct bilirubin important?
To detect cholestasis and enable timely referral
246
Why is suspected biliary atresia urgent?
It is a surgical emergency
247
What procedure treats biliary atresia?
Kasai portoenterostomy
248
When should Kasai portoenterostomy ideally be performed?
Before 45–60 days of life
249
What is the benefit of early Kasai portoenterostomy?
Improved native liver survival
250
What is the purpose of post-Kasai antibiotic prophylaxis?
Prevention of cholangitis
251
Which antibiotics may be used for post-Kasai cholangitis prophylaxis?
TMP-SMX or neomycin
252
What is the role of adjuvant steroids after Kasai portoenterostomy?
Improve bile drainage according to institutional pathways
253
What nutritional support is recommended after Kasai portoenterostomy?
High-calorie feeding at 130–150% of estimated average requirement
254
What type of formula is recommended in cholestatic infants?
MCT-enriched formula
255
Which vitamins require water-soluble supplementation in cholestasis?
Vitamins A, D, E, and K
256
What is the purpose of phototherapy in neonatal unconjugated hyperbilirubinemia?
Lower serum bilirubin
257
What factors determine phototherapy thresholds?
Hour-specific TSB, gestational age, and neurotoxicity risk factors
258
What are neurotoxicity risk factors for neonatal hyperbilirubinemia?
Sepsis, hemolysis, acidosis, and low albumin
259
What type of light is used for intensive phototherapy?
High-intensity LED
260
What is the recommended intensive phototherapy irradiance in the lecture?
30 W/cm²/nm
261
What should intensive phototherapy maximize?
Surface area exposed to light
262
When is IVIG considered in immune hemolytic disease?
When TSB rises despite intensive phototherapy or approaches exchange level
263
What is the IVIG dose for immune hemolytic disease?
$0.5–1.0$ g/kg
264
When is exchange transfusion indicated?
Critical TSB levels or signs of acute bilirubin encephalopathy
265
What does ABE stand for?
Acute bilirubin encephalopathy
266
What neonatal stool finding requires immediate pediatric GI referral?
Acholic or clay-colored stools
267
What urine finding is a red flag for neonatal cholestasis?
Dark tea-colored urine
268
What should be suspected in an ill-appearing jaundiced infant?
Bacterial sepsis, HSV, or metabolic decompensation
269
What metabolic disease may cause severe neonatal jaundice?
Galactosemia
270
Should breast milk jaundice be diagnosed before excluding conjugated hyperbilirubinemia?
No
271
In what form should fat-soluble vitamins be supplemented during severe cholestasis?
Water-soluble or solubilized form
272
What are the six PFIC-related genes listed in the lecture?
ATP8B1, ABCB11, ABCB4, TJP2, NR1H4, and MYO5B
273
What does IBAT stand for?
Ileal bile acid transporter
274
Which drugs are IBAT inhibitors?
Odevixibat and maralixibat
275
What is the therapeutic role of odevixibat and maralixibat?
Reduce cholestatic pruritus and serum bile acids
276
Which conditions may be treated with IBAT inhibitors?
PFIC and Alagille syndrome
277
What potential surgical benefit do IBAT inhibitors provide?
Reduced need for biliary diversion in selected patients
278
What causes breastfeeding jaundice?
Insufficient fluid intake during the first week of life
279
What complications may occur in breastfeeding jaundice?
Dehydration and hypernatremia
280
When does breastfeeding jaundice commonly occur?
During the first week of life
281
What is breast milk jaundice?
Persistent indirect hyperbilirubinemia in thriving, healthy, well-fed infants
282
What type of bilirubin is elevated in breast milk jaundice?
Unconjugated bilirubin
283
What substances in breast milk contribute to breast milk jaundice?
Inhibitors of glucuronyl transferase
284
How does breast milk affect bilirubin absorption?
Enhances intestinal bilirubin absorption
285
When does breast milk jaundice typically become evident?
Later than breastfeeding jaundice
286
When does breast milk jaundice generally decline?
During the second to third week of life
287
What should be considered in severe or persistent neonatal jaundice?
Other medical causes
288
What temporary feeding change may be considered for persistently high bilirubin?
Formula for 24–48 hours
289
Does phototherapy require cessation of breastfeeding?
No
290
When should breastfeeding resume after temporary formula feeding?
After serum bilirubin declines
291
What should parents do with breast milk during temporary formula feeding?
Continue expressing and collecting breast milk
292
What are the main differences between breastfeeding jaundice and breast milk jaundice?
Breastfeeding jaundice is due to inadequate intake; breast milk jaundice causes prolonged indirect hyperbilirubinemia
293
What is the most important bilirubin fraction to check in prolonged neonatal jaundice?
Direct/conjugated bilirubin
294
What is the gold-standard invasive investigation for suspected biliary atresia listed in the lecture?
Intraoperative cholangiogram
Réviser les 294 cartes gratuitement

Plus de flashcards : Médecine et santé

Exam 2 Questions25 cartesMédecine et santé · AnglaisKimSpina Bifida20 cartesMédecine et santé · Anglaisjocyt9funciones rrhh parcial15 cartesMédecine et santé · EspagnolAbrilles voies d'administration et formes pharmaceutiques 11 cartesMédecine et santé · FrançaisClaraPharmacology Exam 2: Renal and Electrolytes167 cartesMédecine et santé · AnglaisStargirl020Psychology 202: Neurotransmitters146 cartesMédecine et santé · AnglaisMayaÁltalános toxikológia100 cartesMédecine et santé · HongroisRitikeHistory of Medicine Through Time76 cartesMédecine et santé · AnglaisViolentImmunology: PRRs, PAMPs, and DAMPs59 cartesMédecine et santé · AnglaisDanielaHemolytic Analyzers Reference Ranges49 cartesMédecine et santé · AnglaisMARIAerreur médicamenteuse et iatrogénie39 cartesMédecine et santé · FrançaisClaraWk 6: Diancephalon31 cartesMédecine et santé · AnglaisKai

Tous les decks : Médecine et santé

Révise ces decks dans l’app

Gratuit sur iPhone, Android, Mac et le web. Ajoute n’importe quel deck à ton compte en un tap.

Télécharger dans l’App StoreDisponible sur Google Play
Réviser les 294 cartes gratuitement